MedPath

EMINASE 30 UNITS

EMINASE 30 UNITS

Discontinued
DIN Number

02229390

Drug Class

Human

Market Date

Dec 15, 1997

Company
HC

Wellspring Pharmaceutical Canada Corp

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229390
AIG Number0122566002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B01AD03 ANISTREPLASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANISTREPLASEActive
Strength: 30 UNIT / 5 ML
Monograph: ANISTREPLASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.